Repaglinide and Related Hypoglycemic Benzoic Acid Derivatives
W. Grell(Boehringer Ingelheim (Germany)), Peter Müller(Boehringer Ingelheim (Germany)), E. Rupprecht(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Rudolf Hurnaus(Boehringer Ingelheim (Germany)), Robert Sauter(Boehringer Ingelheim (Germany)), Helmut Wittneben(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Gerhart Griss(Boehringer Ingelheim (Germany)), Michael Mark(Boehringer Ingelheim (Germany)), Peter Luger(Boehringer Ingelheim (Germany))
Cited by 89
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
Does gut hormone PYY3–36 decrease food intake in rodents?
|Nature|2004|295